Back to search

Flexotronix Limited

11323342

active
Private Limited Company
Companies House
Health Score
68 / 100

Some Concerns

30/30
Filing
0/30
Financial
38/40
Risk
  • Negative net worth (-10)
  • Current liabilities exceed current assets (-10)
  • Going concern doubt noted in accounts (-10)
  • 1 outstanding charge (-2)

Details

C/O MAPLE WORKS, HOVE, BN3 7ED
Incorporated 23/04/2018

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

62090
Other information technology service activities

Officers

Mr Jeremy Mark Burbidge

director · Since 23/04/2018

ENGINEER

BRITISH · ENGLAND · Age 64

Also on 4 other boards

Professor Robert Stevens

director · Since 23/04/2018

DIRECTOR

BRITISH · UNITED KINGDOM · Age 60

Also on 4 other boards

Mr Niall Antony Armes

director · Since 08/09/2022

DIRECTOR

BRITISH · ENGLAND · Age 56

Also on 2 other boards

Mr Mark Gladwell

director · Since 08/09/2022

DIRECTOR

BRITISH · ENGLAND · Age 51

Also on 3 other boards

Mr Michael Robbat

director · Since 08/09/2022

DIRECTOR

AMERICAN · UNITED STATES · Age 51

Persons with Significant Control

Sapphiros U.K. Ltd

75–100% shares
75–100% votes
Appoint directors

The Emmanuel Building, Suite 2 Chesterford Research Campus, Saffron Walden, CB10 1XL

Reg: 14342320 · Register Of Companies For England And Wales · Private Company Limited By Shares

Notified 08/09/2022

Former PSCs

Professor Robert Stevens

Ceased 08/09/2022

Charges1 outstanding

Charge
outstanding

HSBC INNOVATION BANKING

Created 06/11/2023Registered 16/11/2023
Charge
satisfied

SILICON VALLEY BANK UK LIMITED

Created 13/04/2023Registered 27/04/2023Satisfied 05/12/2023

CompanyRankvs 39024+ SIC 62090 peers
20

Financial strength0th percentile among SIC peers · 0/25
Employees98th percentile among SIC peers · 15/15
LiquidityCurrent ratio 0.4× · 2/20
Longevity8 years trading (max 15) · 8/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10Outstanding charges -10
Show leaderboard
How is this score calculated?
Financial strength0/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees15/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity2/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity8/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Outstanding charges: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

expansion or future commercialisation efforts in the field of women’s health respiratory and infectious disease detection, which would significantly reduce the required cash needed to continue as a going concern in the ordinary course of business. The directors of the parent company do not believe there is a material uncertainty regarding the parent company’s ability to secure sufficient financi

Key FinancialsYear ending 31/12/2024

Net Worth

-£3.8M

Balance sheet strength

Cash

£397k

Cash in the bank

Net Current Assets

-£2.4M

Working capital

Current Assets

£1.6M

Current Liabilities

£4.0M

Fixed Assets

£11.7M

Debtors

£1.2M

23avg. employees+16

Balance Sheet

Intangible assets£79k
Assets less current liabilities£9.3M
Prepared with Caseware UK (AP4) 2024.0.164

EstimatesDerived

YearCurrent RatioImplied Profit
20240.40-£4.0M
202113.64+£95k
20203.09
20201.03
20190.30

Derived from filed accounts. Not audited figures.